• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500400-28
Device Problems Difficult to Remove (1528); Device Dislodged or Dislocated (2923); Component Misassembled (4004)
Patient Problem Foreign Body In Patient (2687)
Event Date 02/08/2024
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat a heavily calcified, mildly tortuous left anterior descending artery that is 80% stenosed.The vessel was pre-dilated with an non-abbott device.A 3.5 guide was first selected; however did not provide adequate support therefore, a 6fr guideline was used to facilitate the delivery of the stents.An unspecified stent was previously deployed and a 4.0x28mm xience sierra stent delivery system (sds) was advanced too far forward; therefore, was pulled back to reposition to desired location.The sds met resistance with anatomy and the previously implanted stent.The stent partially dislodged and movement of the balloon markers was noted; however, stent was deployed by inflating the delivery system not the intended position in the mid lad layered on the previously implanted stent.A third stent unspecified xience sierra stent was successfully implanted to treat the target lesion at the proximal lad and left main artery.There was no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties related to difficulty to remove (stent and anatomy) and stent dislodgement appear to be related to circumstances of the procedure.The investigation was unable to determine a conclusive cause for the reported component misassembled (marker band misalignment).There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: health effect - impact code 4641 removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18820183
MDR Text Key336695948
Report Number2024168-2024-02643
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1500400-28
Device Lot Number3051041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2024
Initial Date FDA Received03/01/2024
Supplement Dates Manufacturer Received03/05/2024
Supplement Dates FDA Received03/15/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6FR GUIDELINE
Patient Outcome(s) Other;
-
-